Details for New Drug Application (NDA): 016379
The generic ingredient in LOCORTEN is flumethasone pivalate. There is one drug master file entry for this compound. Additional details are available on the flumethasone pivalate profile page.
Summary for 016379
| Tradename: | LOCORTEN |
| Applicant: | Novartis |
| Ingredient: | flumethasone pivalate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016379
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 0.03% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Expired US Patents for NDA 016379
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Novartis | LOCORTEN | flumethasone pivalate | CREAM;TOPICAL | 016379-001 | Approved Prior to Jan 1, 1982 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
